Type 2 Diabetes

As outlined by the authors, use of metformin is an appealing option because it is safe, produces few side effects, and is a cost-effective way to target some of the defects known to contribute to the metabolic defects associated with diabetes.

In the cohort study conducted by Ahmed and colleagues, the investigators assessed whether diabetes was associated with worse outcomes in heart failure regardless of the associated risk factors and comorbidities.

The benefits of implantable cardioverter-defibrillators (ICDs) have been shown in randomized clinical trials. The factors that affect the risk–benefit ratio in a community setting, however, have not been evaluated.

Manhattan Research, a healthcare market research company, released a survey on Monday announcing the top 10 pharmaceutical product sites visited by physicians.

The American Academy of Pediatrics is now recommending cholesterol-reducing medications for high-risk kids.

This propensity-matched study, in which patients with and without diabetes were well balanced in all measured baseline characteristics, including traditional risk factors and comorbidities, found that diabetes was associated with increased mortality and hospitalization in ambulatory patients who had chronic, mild-to-moderate heart failure and were receiving angiotensin-converting enzyme inhibitors. These findings also highlight the sex- and age-related variations in the effect of diabetes in these patients.

Data interpretation and management has become increasingly more challenging and time consuming.

Columbia Medical School researchers at the Naomi Berrie Diabetes Center have found that the common Asian cooking spice turmeric may help prevent diabetes.

A recent meta-analysis of 31 randomized controlled trials with 4500 participants showed that metformin treatment significantly decreased weight, improved dyslipidemia and insulin resistance, and reduced the incidence of new-onset diabetes by 40%, with beneficial effects maintained over time. Further studies will show whether the metabolic improvements achieved with metformin treatment will ultimately result in a decrease in cardiovascular morbidity and mortality.

Researcher George King, MD, presented data at the annual JDRF conference, showing that individuals with type 1 diabetes still have the ability to produce insulin.

Cardiovascular disease accounts for 65 percent of patient deaths among people with type 2 diabetes.

The UT Southwestern Medical Center has genetically engineered a laboratory mouse, named the PANIC-ATTAC mouse, that can regenerate pancreatic beta cells after these cells have been induced to die.

Hemodialysis has evolved over the last 50 years as a life-saving treatment for people with renal failure. Now, there is a new treatment.

A federal review of insulin pump use by adolescents over a period of 10 years found that 13 deaths and more than 1,500 injuries were connected with the pumps.

Among the pregnant women researched in a recent study on diabetes, 2,784 had either type 1 or type 2 diabetes before getting pregnant.

MDNG spoke with Robert C. Like, MD, MS, Professor and Director of the Center for Healthy Families and Cultural Diversity, Department of Family Medicine, UMDNJ-Robert Wood Johnson Medical School, to discuss his efforts to improve cultural competency in healthcare.

What has changed in diabetes medicine over the years? In this ongoing series exploring "Old Tyme Medicine," Bradley Schmidt takes a look at treating diabetes -- then, now, tomorrow, and beyond.